Vaccination against shingles in the future, will be paid for all persons over the age of 60 years and for younger persons with elevated health risk of statutory health insurance funds. The Federal Joint Committee has decided. The Inactivated vaccine is in may 2018.
According to studies by the Robert Koch Institute (RKI) in Germany are diagnosed annually, significantly more than 300,000 people to Herpes zoster as shingles is also known. About five percent of them develop as a complication of post-herpetic neuralgia – the pain is agonizing nerves, the weeks to months after Healing of the rash remain.
In December of last year, the Standing Committee on vaccination (STIKO) at the RKI, the vaccination against Herpes zoster (aponet.de reported). The STIKO reasons for its recommendation, particularly severe disease courses in older persons from 60 years of age occur more frequently. Who is at risk due to an underlying disease also, if the recommendation to 50 years of age should be vaccinated. These include underlying diseases such as:
- congenital or acquired immunodeficiency
- HIV infection
- rheumatoid Arthritis
- systemic Lupus erythematosus
- chronic inflammatory bowel diseases
- chronic obstructive pulmonary disease or bronchial Asthma
- chronic renal failure
- Diabetes mellitus
The decision to Amend the protection of vaccination policy will be submitted to the Federal Ministry of health for examination and occurs after publication in the Federal Gazette.
GbA/NK
An Overview of all the messages you get on aponet.de current.